In addition, Drak2 has been reported to be involved in the pathogenesis of other metabolic diseases, such as nonalcoholic fatty liver disease, and the mechanism by which Drak2 affects mitochondrial function through alternative splicing has been elucidated. This evidence concerns the gene STK17B and metabolic disease.